Runx1 drives cardiac fibrosis and heart failure through epigenetic activation of myofibroblasts in pressure overload-induced cardiac remodeling. [PDF]
An J +11 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
ER-phagy Activation by AMFR Attenuates Cardiac Fibrosis Post-Myocardial Infarction via mTORC1 Pathway. [PDF]
Wang Z +10 more
europepmc +1 more source
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure. [PDF]
Ghazal R +4 more
europepmc +1 more source
Causes, Diagnosis, Treatment, and Prognosis of Cardiac Fibrosis: A Systematic Review. [PDF]
BaniHani HA +6 more
europepmc +1 more source
Tcf21 modulates fibroblast activation and promotes cardiac fibrosis after injury via Pdgfrb signaling. [PDF]
Baba Y +26 more
europepmc +1 more source
Epigenetic modifications in cardiac fibrosis: recent evidence of new pharmacological targets. [PDF]
Pérez M +5 more
europepmc +1 more source
Targeting Cardiac Fibrosis With a Vaccine Against Fibroblast Activation Protein. [PDF]
Oldham WM.
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala +1 more
wiley +1 more source
Related searches:
Ketogenic diets inhibit mitochondrial biogenesis and induce cardiac fibrosis
Signal Transduction and Targeted Therapy, 2021Sha Xu, Wei Cao, Li Cao
exaly

